The Tyho-Galileo Research Team
consists of preimplantation geneticist Santiago Munné,
PhD, veterinary experimental embryologist and nuclear
transplantation pioneer Steen Willadsen, DVM, D.Sc., as well as
leading molecular biologists and experimental embryologists
George Pieczenik, Ph.D., Mina Alikani, Ph.D., James J.
Stachecki, Ph.D., Nury Steuerwald, Ph.D., and Dagan Wells, Ph.D. Jacques Cohen, Ph.D. leads the team and
has contributed to establishing human embryo cryopreservation,
assisted fertilization and hatching technologies. Program
services are directed by Kelly Ketterson, M.Sc. Tim Schimmel
B.Sc., oversees research and clinical activities. These
scientists will be responsible for designing and conducting
embryology research, genomics and proteomics, as well as for
overseeing collaboration with research scientists, reproductive
endocrinologists and others at designated Tyho-Galileo Centers
worldwide.
Members
of the team are currently involved in many clinical trials, as
well as in more than two dozen key studies at several centers,
and
Tyho-Galileo scientists already provide services at embryology
laboratories in numerous U.S. cities and at facilities
throughout the world.
Members of the
Tyho-Galileo
Research Team have contributed significantly to the
extraordinary success rates experienced at the many centers in
North and South America, Europe and Asia with which they have
been affiliated. Beyond this,
Tyho-Galileo’s
founders have aided hundreds of additional centers worldwide
with their unselfish sharing of scientific and practical
findings, through more than 500 publications in such peer review
journals as Nature, Biology of Reproduction, Molecular Human
Reproduction, The Lancet, Proceedings of The National Academy of
Science USA, and Reproductive Biomedicine Online, and
hundreds of lectures, courses and educational seminars.
Ongoing
and expanded scientific studies conducted by the
Tyho-Galileo
Research Team are expected to result in the creation of
new methods for gamete and embryo freezing, novel PGD
techniques, new methods of developing and testing stem-cells,
novel ways of assessing embryonic health prior to transfer and
new methods of enhancing embryonic development. Since the
inception of Tyho-Galileo scientists have developed a new method
of vitrifying human blastocysts, embryos, and oocytes called S3
vitrification and a new culture system called
Global medium.
Scientists at Tyho-Galileo have endeavored in the origins of
human embryo fragmentation and have come closer in explaining
this most frequent anomaly in early human development.
